Diagnostic Criteria for Acute Kidney Injury: Present and Future

Critical Care Clinics

Volumn 31, Issue 4, 2015, Pages 621-632

  Kellum, John A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Biomarkers; Clinical trials; Dialysis; Mortality; Renal recovery; Renal replacement therapy

Indexed keywords

BIOLOGICAL MARKER; CREATININE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; SOMATOMEDIN BINDING PROTEIN; TIMP2 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ACUTE KIDNEY FAILURE; AGE DISTRIBUTION; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MEDICAL HISTORY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; URINE VOLUME; ACUTE KIDNEY INJURY; BLOOD; COMPLICATION; OLIGURIA; PATHOPHYSIOLOGY; URINE;

ACUTE KIDNEY INJURY; BIOMARKERS; CREATININE; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; OLIGURIA; PRACTICE GUIDELINES AS TOPIC; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84942197492     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2015.06.001     Document Type: Review

References (39)

1. Diamandopoulos A. Twelve centuries of nephrological writings in the Graeco-Roman world of the Eastern Mediterranean (from Hippocrates to Aetius Amidanus). Nephrol Dial Transplant 1999, 14(Suppl 2):2-9.
2. Kellum J.A. Acute kidney injury. Crit Care Med 2008, 36:S141-S145.
3. Kidney disease: improving global outcomes (KDIGO) clinical practice guideline for acute kidney injury work group (AKIWG). Kidney Int Suppl 2012, 2:1-138. 1-141.
4. Eknoyan G. Emergence of the concept of acute kidney injury. Adv Chronic Kidney Dis 2008, 15:308-313.
5. Bywaters E.G., Beall D. Crush injuries with impairment of renal function. Br Med J 1941, 1:427-432.
6. Bellomo R., Ronco C., Kellum J.A., Acute Dialysis Quality Initiative Workgroup, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212.
7. Mehta R.L., Kellum J.A., Shah S.V., Acute Kidney Injury Network, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31.
8. Hoste E.A.J., Clermont G., Kersten A., et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006, 10:R73.
9. Uchino S., Bellomo R., Goldsmith D., et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients*. Crit Care Med 2006, 34:1913-1917.
10. Sileanu F.E., Murugan R., Lucko N., et al. AKI in low-risk versus high-risk patients in intensive care. Clin J Am Soc Nephrol 2015, 10(2):187-196. Available at:. http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25424992&retmode=ref&cmd=prlinks.
11. Siew E.D., Matheny M.E., Ikizler T.A., et al. Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int 2010, 77:536-542.
12. Závada J., Hoste E., Cartin-Ceba R., et al. AKI6 investigators: a comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant 2010, 25:3911-3918.
13. Vincent J.L., Moreno R., Takala J., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
14. Kellum J.A., Sileanu F.E., Murugan R., et al. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol 2015, [Epub ahead of print].
15. Ralib A.M., Pickering J.W., Shaw G.M., et al. The urine output definition of acute kidney injury is too liberal. Crit Care 2013, 17:R112.
16. Macedo E., Malhotra R., Bouchard J., et al. Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int 2011, 80:760-767.
17. Chawla L.S., Davison D.L., Brasha-Mitchell E., et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care 2013, 17:R207.
18. Sutherland S.M., Zappitelli M., Alexander S.R., et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 2010, 55:316-325.
19. Bouchard J., Soroko S.B., Chertow G.M., Program to Improve Care in Acute Renal Disease (PICARD) Study Group, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009, 76:422-427.
20. Boyd J.H., Forbes J., Nakada T.-A., et al. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011, 39:259-265.
21. Liu K.D., Thompson B.T., Ancukiewicz M., National Institutes of Health National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network, et al. Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit Care Med 2011, 39:2665-2671.
22. Coca S.G., King J.T., Rosenthal R.A., et al. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int 2010, 78:926-933.
23. Palevsky P.M., Molitoris B.A., Okusa M.D., et al. Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol 2012, 7(5):844-850.
24. Okusa M.D., Molitoris B.A., Palevsky P.M., et al. Design of clinical trials in acute kidney injury: a report from an NIDDK workshop-prevention trials. Clin J Am Soc Nephrol 2012, 7(5):851-855.
25. Molitoris B.A., Okusa M.D., Palevsky P.M., et al. Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. Clin J Am Soc Nephrol 2012, 7(5):856-860.
26. Murugan R., Kellum J.A. Acute kidney injury: what's the prognosis?. Nat Rev Nephrol 2011, 7:209-217.
27. Chen L, Koyner JL. Biomarkers in Acute Kidney Injury. 2015, in press.
28. Murray P.T., Mehta R.L., Shaw A., et al. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th acute dialysis quality initiative consensus conference. Kidney Int 2014, 85:513-521.
29. Kashani K., Al-Khafaji A., Ardiles T., et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013, 17:R25.
30. Hoste E.A.J., McCullough P.A., Kashani K., Sapphire Investigators, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant 2014, 29:2054-2061.
31. Bihorac A., Chawla L.S., Shaw A.D., et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014, 189:932-939.
32. Preisig P.A., Franch H.A. Renal epithelial cell hyperplasia and hypertrophy. Semin Nephrol 1995, 15:327-340.
33. Shankland S.J. Cell cycle regulatory proteins in glomerular disease. Kidney Int 1999, 56:1208-1215.
34. Yang L., Besschetnova T.Y., Brooks C.R., et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010, 16:535-543.
35. Meikrantz W., Schlegel R. Apoptosis and the cell cycle. J Cell Biochem 1995, 58:160-174.
36. Megyesi J., Safirstein R.L., Price P.M. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 1998, 101:777-782.
37. Zeng X., McMahon G.M., Brunelli S.M., et al. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol 2014, 9:12-20.
38. Koyner J.L., Shaw A.D., Chawla L.S., et al. Tissue inhibitor metalloproteinase-2 (TIMP-2) and IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol 2015, 26:1747-1754.
39. Kellum J.A., Devarajan P. What can we expect from biomarkers for acute kidney injury?. Biomark Med 2014, 8:1239-1245.